— Know what they know.
Not Investment Advice

SLDX OTC

Stella Diagnostics Inc.
1W: +24.1% 1M: +24.1% 3M: -3.1% YTD: -35.4% 1Y: -50.0% 3Y: -90.9% 5Y: -99.0%
$0.01
+0.00 (+24.07%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 52 · $975507 mcap · 22M float · 0.121% daily turnover · Short 70% of daily vol

Balance Sheet Trends

Total Assets
$189K -59.9% ▼
5Y CAGR: -20.9%
Total Liabilities
$19M +5.3% ▲
5Y CAGR: +25.0%
Shareholders Equity
-$19M -7.0% ▼
Cash & Investments
$5K -35.6% ▼
5Y CAGR: +46.3%
Total Debt
$7M +7.1% ▲
5Y CAGR: +32.9%
Net Debt
$7M +7.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$37K$1K$1K$8K$5K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$37K$1K$1K$8K$5K
Net Receivables$0$0$0$10K$10K
Inventory$0$0$0$0$0
Other Current Assets$0$583$583$3K$10K
Total Current Assets$40K$2K$2K$20K$25K
Property, Plant & Equip.$0$0$0$0$165K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$452K$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$452K$165K
Total Assets$40K$2K$2K$472K$189K
— Liabilities —
Accounts Payable$905K$1M$1M$138K$229K
Short-Term Debt$702K$7M$8M$5M$7M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$4M$12M$13M$7M$7M
Total Current Liabilities$10M$20M$22M$17M$19M
Long-Term Debt$628K$272K$272K$798K$0
Other Non-Current Liab.$40K$193M$0$0$0
Total Non-Current Liabilities$668K$193M$272K$798K$66K
Total Liabilities$11M$213M$22M$18M$19M
— Equity —
Common Stock$10K$10K$30K$40K$40K
Retained Earnings-$14M-$214M-$223M-$229M-$230M
Accumulated OCI-$10K$0-$30K-$40K$0
Total Stockholders Equity-$11M-$213M-$22M-$18M-$19M
Total Liabilities & Equity$40K$2K$2K$472K$189K
— Key Metrics —
Total Debt$1M$7M$8M$6M$7M
Net Debt$1M$7M$8M$6M$7M
Total Investments$0$0$0$452K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms